CardiacWire

APRIL 2, 2025

25 saw a deluge of pharmaceutical solutions across the spectrum of heart disease, from HCM all the way to LDL (detection and treatment just have to catch up). Better Understanding TAVR While TAVR has earned its reputation for safety and efficacy, several late breaking trials helped clarify ways to improve it and even complicate it.

Reimbursement 64

Reimbursement TAVR Research Innovation 64

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 105

TAVR Academic Education Cardiovascular Surgery 105

The New England Journal of Medicine

OCTOBER 29, 2024

The past two decades have witnessed a renaissance in the evaluation and treatment of patients with valvular heart disease, catalyzed by advances in surgical innovation, transcatheter techniques, and multimodality cardiac imaging.

Aortic valve 40

Aortic valve Tricuspid TAVR Aortic 40

DAIC

MARCH 15, 2024

Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MARCH 21, 2024

To this end, ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services.

Pediatrics 86

Pediatrics Outcomes Patient Care Anatomy 86